Abstract #505O, Proffered Paper Oral Session: 2, Madrid Auditorium –Hall 2, Sunday, September 15 from 3:05 - 3:15 p.m. CEST AMG 193 Phase 1 dose escalation and initial dose expansion results of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients (pts) with...
The article provides information on the European Congress of the European Society for Medical Oncology (ESMO) held in Madrid, Spain, from October 20 to 24, 2023. It mentions that the conference was focused on several key topics, including the correlation between alcohol consump...
ESMO 2023 Congress - European Society for Medical Oncology - 20-24 Oct 2023, Feria De Madrid (IFEMA), Spain (25994) Important Please, check "ESMO Congress - European Society for Medical Oncology" official website for possible changes, before making any traveling arrangementsEvent Categories Health...
Marseille, France, October 16, 2023–ImCheck Therapeuticsannounced today that updated data from its ongoing Phase I/IIa clinical trial EVICTION will be presented at the European Society for Medical Oncology (ESMO) Congress in an oral session on October 22ndi...
CDR404 (Abstract 200P), a first-of-its-kind bispecific and bivalent antibody fragment-based T-cell engager (TCE) targeting MAGE-A4, an intracellular protein which is presented on HLA-A*02:01 on the surface of cancer cells, at t...
“ESMO”) Immuno-Oncology Congress 2023, an international conference held in Madrid, Spain, from October 20thto 24th. At the ESMO Congress 2023, Junshi Bioscience showcased a total of 11 clinical trials involving the groundbreaking immune-oncology drug, toripalimab (anti-PD-1 mo...
(ESMO) Congress 2023. The event will take place on Sunday, October 22, 2023 from 8:00pm – 10:00pm CEST (2:00pm – 4:00pm ET) at the Santo Mauro Hotel in Madrid, Spain. Discussions will feature preliminary safety, efficacy, and pharmacokinetic (PK) data from APEX-...